Clearance Of Mucus In Stents (COMIS)
2 other identifiers
interventional
43
1 country
1
Brief Summary
The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2011
CompletedFirst Posted
Study publicly available on registry
June 9, 2011
CompletedStudy Start
First participant enrolled
June 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2023
CompletedAugust 25, 2023
August 1, 2023
12.2 years
June 8, 2011
August 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of obstruction resolution as Good or Excellent
Response/efficacy of sodium bicarbonate versus normal saline in airway stents graded using scale. Percentage of obstruction resolution (relative to initial stent lumen obstruction by mucus): Good response 51-75% clearance; and Excellent 76 - 100% clearance. The Mantel-Haenszel chi-square test stratified by degree of lumen obstruction at study enrollment used to compare response (good or excellent obstruction resolution) rates between treatment arms.
Baseline to 7 days
Study Arms (2)
Normal Saline
ACTIVE COMPARATORNormal saline sprayed into stent/airway tubes then suctioned out through bronchoscope.
Sodium Bicarbonate
ACTIVE COMPARATORSodium bicarbonate sprayed into stent/airway tubes then suctioned out through bronchoscope.
Interventions
Normal saline administered in stent/airway tubes under direct visualization via the bronchoscope.
4.2% bicarbonate solution mixed with equal volume of sterile water administered into stent/airway tubes under direct visualization via the bronchoscope.
Eligibility Criteria
You may qualify if:
- Adult patients (\>/= 18 years) with airway stents undergoing bronchoscopy.
- Patients previously enrolled, but excluded as no stent lumen obstruction from mucus retention identified at earlier enrollment (hence excluded at that enrollment) .
You may not qualify if:
- Patients with history of allergy or adverse reactions to sodium bicarbonate or normal saline.
- Patients refusing to sign informed written consent for participation in research.
- Patients with no stent lumen occlusion from mucus impaction as determined at the time of the initial visual bronchoscopic assessment.
- Previously enrolled patients who completed this protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos A. Jimenez, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2011
First Posted
June 9, 2011
Study Start
June 16, 2011
Primary Completion
August 23, 2023
Study Completion
August 23, 2023
Last Updated
August 25, 2023
Record last verified: 2023-08